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Perchloric acid and most perchlorate salts, 
which are widely used as oxidants in aero­
space fuels and explosives, readily dissolve in 
water generating the perchlorate anion, ClO4
– 
(perchlorate). Perchlorate is persistent, exhib­
its poor affinity for soils, is highly mobile in 
groundwater, and has been detected nationally 
in groundwater and surface water associated 
with the aerospace industry, military bases, 
and blasting sites [Massachusetts Department 
of Environmental Protection (MA DEP) 
2005; U.S. Environmental Protection Agency 
(EPA) 2002c]. Other potential sources 
include fireworks, hypochlorite water disin­
fection products, and certain manufacturing 
processes (MA DEP 2005; U.S. EPA 2002c). 
Perchlorate compounds also occur naturally in 
Chilean nitrate fertilizers, evaporite soils, and 
the atmosphere (Dasgupta et al. 2005).
Perchlorate is of toxicological concern 
because it interferes with iodide uptake in 
the thyroid and can disrupt the synthe­
sis of thyroid hormones critical to normal 
growth, development, and other physiologi­
cal functions [Greer et al. 2002; National 
Research Council (NRC)	2005;	Yu	et	al.	
2002]. Because of widespread environmen­
tal contamination, people can be exposed to 
perchlorate found in drinking water, breast 
milk, foods, and beverages. Many food items 
accumulate perchlorate from contaminated 
soil	and	water	(Yu	et	al.	2004), and human 
biomonitoring data have demonstrated wide­
spread exposures attributed to dietary sources 
[Blount et al. 2006b; El Aribi et al. 2006; 
Food and Drug Administration (FDA) 2009; 
Valentin­Blasini et al. 2005].
In 2001 and 2002, perchlorate was 
detected in groundwater at the Massachusetts 
Military Reservation and the town of Bourne 
on Cape Cod, respectively. Because no state 
or federal drinking water standard (DWS) (or 
maximum contaminant level) was available, 
MA DEP, with input from an independent 
science advisory committee (SAC), derived a 
reference dose (RfD) of 0.07 µg/kg/day for 
perchlorate using a weight­of­the­evidence 
approach that considered data from mode 
of action, human, and animal studies. An 
RfD provides an estimate of the daily dose 
of a chemical likely to be without deleteri­
ous effects over a lifetime, with uncertainty 
of about an order of magnitude (U.S. EPA 
2002a). Following extensive public input, a 
MA perchlorate DWS of 2 µg/L was adopted 
in 2006. In this review, we summarize the 
scientific basis and risk management decisions 
supporting these values and compare the MA 
values with those derived by the NRC (RfD = 
0.7 µg/kg/day), U.S. EPA [interim drinking 
water health advisory (IDWHA) = 15 µg/L], 
and California (DWS = 6 µg/L).
Key Studies, Data Sources, and 
Toxicological Considerations for 
Perchlorate Risk Assessment
Toxicokinetics. Ingested perchlorate is exten­
sively absorbed from the gastrointestinal sys­
tem and accumulates in the thyroid (MA DEP 
2006; NRC 2005; U.S. EPA 2002c). Most 
absorbed perchlorate is excreted unchanged 
in the urine, with a biological half­life of 
about 8 hr (Lamm et al. 1999; Wolff 1998). 
Biphasic clearance with a second­phase half­
life of 70–80 hr in rats has been reported (Von 
Burg 1995). This pattern is consistent with a 
multi  compartment model with accumulation 
and slow clearance from at least one compart­
ment, likely to include the thyroid.
Perchlorate crosses the placenta and has 
been detected in amniotic fluid (Blount and 
Valenti­Blasini 2006). It is also secreted into 
human breast milk and may reduce iodine levels 
in the milk (Dasgupta et al. 2008). All breast 
milk samples collected from 36 women from 
18 states contained perchlorate at concentra­
tions ranging from 1.4 to 92.2 µg/L (mean = 
10.5 µg/L; median = 3.25 µg/L) (Kirk et al. 
2005). Perchlorate in 147 samples of breast milk 
from 10 women ranged from 0.5 to 39.5 µg/L 
(mean ± SD = 5.8 ± 6.2 µg/L; median = 4 µg/L) 
(Kirk et al. 2007). Forty­nine samples of breast 
milk from women in Boston all contained per­
chlorate ranging from 1.3 to 411 µg/L (mean 
± SD = 33 ± 77 µg/L; median = 9.1 µg/L). No 
association was found between milk perchlo­
rate and iodine content, but an estimated 47% 
of the women may have been expressing milk 
with insufficient iodine (Pearce et al. 2007b). In 
> 400 samples of breast milk from 13 women, 
perchlorate ranged from 0.01 to 48 µg/L 
(mean ± SD = 9.3 ± 7.5 µg/L; median = 
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7.3 µg/L); compared with iodide, perchlorate 
was estimated to be preferentially secreted into 
milk, and breast milk from 12 of the 13 women 
did not contain adequate iodine (Dasgupta et al. 
2008). Preferential secretion of perchlorate over 
iodide into breast milk would reduce the nursing 
infant’s iodide intake and exacerbate neo  natal 
thyroid sensitivity to perchlorate in the milk.
Mode of action. The thyroid gland trans­
ports and concentrates iodide from the blood, 
which is necessary for the synthesis of the 
thyroid hormones thyroxin (T4) and triiodo­
thyronine (T3) (NRC 2005). Iodide transport 
is mediated by the sodium (Na)–iodide (I) 
symporter (NIS), an integral membrane protein 
present in the thyroid, the mammary gland, 
and other tissues (Vieja et al. 2000). Perchlorate 
competitively inhibits iodide transport by the 
NIS (Greer et al. 2002; NRC 2005; Wolff 
1998) and promotes the discharge of endog­
enous thyroidal iodide through a mechanism 
that is not well understood (Bürgi et al. 1974; 
Wolff 1998; Wyngaarden et al. 1952). These 
actions reduce iodide availability for synthesis 
of T4 and T3 (Greer et al. 2002; Wyngaarden 
et	al.	1952;	Yu	et	al.	2002).	Perchlorate	is	also	
actively transported into thyrocytes (Dohán 
et al. 2007; Tran et al. 2008).
Although NIS inhibition is viewed as per­
chlorate’s primary mode of action, other pos­
sible mechanisms that could contribute to its 
toxicity may exist. Based on a biologically based 
dose–response model of the hypothalamus– 
pituitary–thyroid axis and physiologically based 
pharmacokinetically (PBPK) modeled per­
chlorate distribution and inhibition of thyroid 
iodide uptake, a recent assessment concluded 
that iodide uptake inhibition (IUI) was insuf­
ficient to explain observed changes in rat thy­
roid hormone levels attributable to perchlorate 
(McLanahan et al. 2009). These results suggest 
that an additional mechanism of action may 
exist, perhaps attributable to perchlorate uptake 
into the thyroid and interference with other tar­
gets involved in hormone synthesis and release. 
The pendrin protein, which mediates iodide 
transport across the thyroidal apical membrane 
into the follicular lumen, where it is used in the 
iodination of thyroglobulin, is one such pos­
sible target (MA DEP 2006; Scinicariello et al. 
2005). Mutations in the pendrin protein result 
in defects in iodide transport into the follicular 
lumen and impaired iodide organification. The 
resulting iodide accumulation in the thyrocyte 
may exacerbate perchlorate­induced iodide dis­
charge (Scinicariello et al. 2005). Perchlorate 
interference with the pendrin protein could 
similarly exacerbate iodide discharge or directly 
lead to decrements in organification.
Decreases in the serum levels of thyroid 
hormones trigger a feedback system involving 
the hypothalamus–pituitary–thyroid axis (NRC 
2005). The hypothalamus uses thyrotropin­ 
releasing hormone (TRH) to control the 
pituitary gland, which in turn controls the 
thyroid through thyroid­stimulating hormone 
(TSH). Secretion of TRH, and hence TSH, is 
typically increased by low blood levels of thy­
roid hormones in a classical negative feedback 
loop. This homeostatic mechanism, as well as 
the storage of excess thyroid hormone by the 
healthy mature thyroid, may mitigate the effects 
of thyroid toxicants (NRC 2005). However, 
because of individual and life­stage variability 
in the effectiveness of these homeostatic con­
trols and in thyroid reserve capacities, potential 
sensitive subgroups must be considered in the 
derivation of exposure limits for perchlorate 
(Ginsberg et al. 2007; MA DEP 2006; Savin 
et al. 2003; Scinicariello et al. 2005; van den 
Hove et al. 1999; Zoeller 2003).
Sensitive subgroups. Based on many lines of 
evidence, fetuses, premature infants, and new­
borns are at greater risk of perchlorate toxicity. 
Appropriate levels of thyroid hormones are 
critical to the development of various organs, 
especially the brain, which occurs during fetal 
growth and childhood (Howdeshell 2002; 
Zoeller et al. 2002). During the fetal and neo­
natal periods, the thyroid gland is incompletely 
developed, increasing susceptibility to toxicants 
that disrupt thyroid function. These life stages 
exhibit low thyroid hormone storage capacity, 
estimated at < 1 day in neonates (Savin et al. 
2003; van den Hove et al. 1999), as well as 
thyroid hormone turnover rates two to three 
times faster than in adults (van den Hove et al. 
1999) and poorly developed adaptive mech­
anisms (Pedraza et al. 2006). Although the 
impact of thyroid toxicants on the fetus can be 
buffered by the thyroid hormone synthesis and 
reserve capacities of the mother, iodide insuffi­
ciency and pregnancy­related stresses on mater­
nal thyroid function increase the potential for 
perchlorate effects during fetal development 
(Ginsberg et al. 2007; Glinoer 2001). In the 
case of the nursing infant, perchlorate secretion 
into breast milk and reported interference with 
iodide transport into the milk (Dasgupta et al. 
2008) present a potential double risk attribut­
able to maternal perchlorate exposure.
Iodine­deficient populations are also likely 
to be at greater risk of perchlorate toxicity 
and provide information relevant to under­
standing potential perchlorate effects. Iodine 
deficiency is strongly associated with poor 
neuro  developmental outcomes (Bleichrodt and 
Born 1994). In areas where iodine intake is 
marginal (< 100 µg/day), low serum T4 and 
T3 levels (hypothyroidism), enlarged thy­
roid, and goiter were often detected in preg­
nant women, with impaired intellectual and 
physical development in offspring (Caron et al. 
1997; Glinoer 2001). Children born to iodine­
deficient mothers had intelligence quotients 
(IQs) 5–13 points lower than children born to 
iodine­sufficient mothers (Bleichrodt and Born 
1994; Van den Briel et al. 2000). Moderate 
iodine deficiency was associated with a 4­fold 
increase in risk of low IQ (Pineda­Lucatero 
et al. 2008), and in an area of mild to moder­
ate iodine deficiency, children with urinary 
iodine < 100 µg/L had significantly lower IQs 
than did those with concentrations > 100 µg/L 
(Santiago­Fernandez et al. 2004). In iodine­
sufficient areas, children of women with free 
T4 levels below the 5th and 10th percentile at 
12 weeks of gestation had significantly lower 
scores on psychomotor development tests at 
10 months of age compared with children 
of mothers with higher T4 (Pop et al. 1999). 
Severe iodine deficiency (< 20 µg/day iodine 
intake) has been associated with stillbirths, 
congenital anomalies, perinatal mortality, and 
cretinism (Delange 2000). Taken together, 
these studies indicate that functional iodine 
deficiency, as could be caused or exacerbated 
by perchlorate exposures in utero and during 
early development, may lead to adverse neuro­
developmental outcomes.
Clinical studies. Six controlled clinical stud­
ies have investigated thyroid effects following 
oral exposures to perchlorate [see Supplemental 
Material, Section B and Table S1, available 
online (doi:10.1289/ehp.0900635.S1 via 
http://dx.doi.org)]. All of these studies included 
small study populations ranging from 5 to 37 
subjects, limiting their overall statistical power 
to detect effects; none addressed pregnant 
women, iodine­deficient groups, or children; 
and only one (Greer et al. 2002) included more 
than two dose groups.
The Greer et al. (2002) study provides the 
best available dose–response information on 
perchlorate­induced IUI and served as the key 
study in the MA DEP, NRC, and California 
Environmental Protection Agency (CalEPA) 
assessments. In this study, perchlorate was 
administered in drinking water at 0.007, 0.02, 
0.1, or 0.5 mg/kg/day to 37 iodine­sufficient 
healthy male and female volunteers for 14 days, 
and radioactive iodide uptake (RAIU) was 
measured at different time points (Greer et al. 
2002). Statistically significant IUI was observed 
in the three highest dose groups. IUI was also 
observed in the 0.007 mg/kg/day group but 
was not statistically significant. The low­dose 
group consisted of only seven subjects, and 
individual relative uptake values exhibited con­
siderable variability. The authors reported a 
no observed effect level of 0.007 mg/kg/day   
(7 µg/kg/day).
Population studies. Several population 
studies have investigated perchlorate expo­
sure and thyroid effects. Adverse health effects 
were not observed in three occupational stud­
ies (Braverman et al. 2005; Gibbs et al. 1998; 
Lamm et al. 1999), although decrements in 
RAIU and alterations in thyroid hormone lev­
els, which the authors did not consider to be 
adverse, were reported by Braverman et al. 
(2005). The applicability of these studies to the Zewdie et al.
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broader population is limited because they did 
not address sensitive life stages or subgroups. 
They were also cross­sectional in design and 
subject to survivor bias.
A number of epidemiological studies of 
ecological design, with exposures largely cate­
gorized by perchlorate concentrations in water 
supplies rather than measurements of individ­
ual exposure, have also been completed. Most 
of these were negative (Crump et al. 2000; 
Kelsh et al. 2003; Lamm and Doemland 1999; 
Li et al. 2000a, 2000b, 2001; Morgan and 
Cassady 2002), with two reporting positive 
associations between putative perchlorate expo­
sures and thyroid effects (Brechner et al. 2000; 
Schwartz 2001). Because perchlorate is present 
in many foods, exposure misclassification in 
these studies is likely significant, reducing their 
statistical power and biasing results toward the 
null hypothesis of no effect.
Several population studies have used uri­
nary perchlorate as a measure of intake, which 
minimizes exposure misclassification and 
allows for more robust data analyses (Amitai 
et al. 2007; Blount et al. 2006a; Gibbs and 
van Landingham et al. 2008; Steinmaus et al. 
2007; Tellez et al. 2005). In an analysis of data 
from a nationally representative group of 2,820 
individuals sampled during the 2001–2002 
National Health and Nutrition Examination 
Survey (NHANES), an association between 
perchlorate exposure levels experienced in the 
general U.S. population and decreased serum 
T4 and increased TSH was observed in women 
with urinary iodine concentrations < 100 µg/L 
(Blount et al. 2006a). An independent analysis 
of the 2001–2002 NHANES data reported 
similar results (Steinmaus et al. 2007). Based 
on 2001–2002 NHANES data, median U.S. 
perchlorate intake was estimated to be 0.066 
µg/kg/day for adults > 20 years of age (Blount 
et al. 2007), and about 36% of U.S. women 
were found to have urinary iodine levels 
< 100 µg/L (Caldwell et al. 2005).
Other studies have reported no association 
between urinary perchlorate and thyroid func­
tion. Tellez et al. (2005) performed a longitudi­
nal epidemiological study of pregnant women in 
Chile exposed to perchlorate in drinking water 
and the diet. The authors concluded that per­
chlorate in drinking water as high as 114 µg/L 
did not affect maternal and neonatal thyroid 
function. However, the applicability of this find­
ing to the United States is uncertain because 
urinary iodine levels in the study populations 
were 30–40% higher in each quintile than those 
reported in NHANES III for pregnant U.S. 
women (Tellez et al. 2005). In a recent analysis, 
no associations between free T4 or TSH and per­
chlorate exposure were found in 16 individuals 
from the Tellez et al. (2005) cohort with urinary 
iodide < 100 µg/L (Gibbs and van Landingham 
2008). Although these results are not support­
ive of the 2001–2002 NHANES findings, the 
sample size is very small. A larger study of three 
European cohorts with median urinary iodine 
< 100 µg/L found no associations between uri­
nary perchlorate and first­trimester serum thy­
roid function tests (Pearce et al. 2007a). The 
significance of these results is difficult to assess 
because little detail on experimental protocols, 
study population characteristics, or statistical 
analyses was provided. In another study, neo­
natal T4 levels were compared between new­
borns in Israel from areas with drinking water 
perchlorate concentrations ranging from < 3 to 
340 µg/L (Amitai et al. 2007). Maternal expo­
sures were estimated from serum perchlorate 
concentrations of donors in each area and were 
consistent with a > 10­fold range in exposures. 
No association between T4 and elevated ges­
tational exposure to perchlorate was observed. 
The authors noted that the study population 
was iodine sufficient and stated that their results 
indicate that the NRC “perchlorate RfD of 0.7 
µg/kg/day is likely to be protective of thyroid 
function in neonates of mothers with adequate 
iodide intake.” However, they also noted that 
because of differences in iodine intake and life 
stages between the studies, their results did not 
contradict those of Blount et al. (2006a).
In summary, although the epidemiologi­
cal studies do not paint a consistent picture 
regarding perchlorate exposure and thyroid 
effects, the largest and most complete assess­
ments to date, Blount et al. (2006a) and 
Steinmaus et al. (2007), did find such an asso­
ciation at doses commonly encountered in the 
general U.S. population.
Animal studies. In summary, the animal 
studies have demonstrated IUI, decreased serum 
T4 and T3, increased TSH, thyroid hypertrophy 
and hyperplasia across life stages, and possible 
alterations in brain morphometry and behavior 
in rat pups exposed to perchlorate in utero and 
after birth (U.S. EPA 2002c) [see Supplemental 
Material, Section C (doi:10.1289/ehp.0900635.
S1)]. These observations are consistent with 
perchlorate’s mode of action. In the most sensi­
tive species, changes in thyroid hormones were 
observed at the lowest dose tested, 0.0085 mg/
kg/day (U.S. EPA 2002c).
MA DEP RfD Derivation
Key study and effect. We chose Greer et al. 
(2002) as the key study for deriving the MA 
perchlorate RfD because it provided the best 
available human dose–response data. The NRC 
and CalEPA also used this study (CalEPA 
2004; NRC 2005). IUI was selected as the crit­
ical effect, which is defined as the first adverse 
effect, or its known precursor, that occurs in 
the most sensitive species as the dose rate of the 
agent increases (U.S. EPA 2002a). IUI is a bio­
chemical change that precedes effects on thy­
roid hormone status. RfDs have been based on 
similar precursor biochemical changes, such as 
plasma or red cell cholinesterase inhibition for 
various organophosphates (U.S. EPA 2005a).
Point of departure. MA DEP considered 
two approaches to derive an RfD for perchlo­
rate: the benchmark dose (BMD) methodol­
ogy, which uses dose–response modeling at a 
selected response rate to derive a point of depar­
ture (POD) for deriving an RfD and a lowest 
observed adverse effect level (LOAEL) approach. 
The U.S. EPA and CalEPA performed BMD 
analyses on the Greer et al. (2002) data using 
a 5% IUI response rate. Excluding two statisti­
cal outliers, the U.S. EPA calculated a 95% 
lower one­sided confidence limit on the BMD 
(BMDL) of 2 µg/kg/day, whereas the CalEPA 
derived a BMDL of 3.7 µg/kg/day (Ting et al. 
2006; U.S. EPA 2002c, 2003). U.S. EPA ulti­
mately adopted the NRC RfD, which relied 
on the lowest dose in the Greer et al. (2002) 
study, 0.007 mg/kg/day (7 µg/kg/day), as the 
POD and treated this value as a no­effect level. 
CalEPA also treated their BMDL as a no­effect 
level and relied on this value as the POD in 
their RfD derivation.
Because we could identify no objective data 
delineating a level of IUI that would not elicit 
downstream effects, we established a POD using 
the LOAEL approach, which does not neces­
sitate the explicit choice of an IUI level of con­
cern. MA DEP used as the POD the lowest dose 
in the Greer et al. (2002) study, where nonstatis­
tically significant IUI was observed, and treated 
this dose as a minimal LOAEL. A minimal 
designation was used because the effect is not 
frankly adverse. The SAC concurred with this 
determination, which was primarily based on 
three observations. First, the Greer et al. (2002) 
study had very low statistical power. Using stan­
dard sample size calculation approaches (Green 
1979; Sokal and Rohlf 1995), the minimum 
difference in RAIU in the Greer et al. study’s 
low perchlorate dose group that could be dis­
criminated from the baseline mean ± SD of 18.1 
± 8.2% was ± 40% at an α of 5% (Figure 1). 
Thus, the Greer et al. (2002) study was unable 
Figure 1. Iodide uptake data from Greer et al. (2002): 
means with low-dose-group baseline SD. The 
shaded box to the left demarcates the range of RAIU 
values (10.9–25.3%) within which differences from 
baseline for 7 µg/kg/day group cannot be statisti-
cally discriminated at an α of 0.05 given sample size 
of 7 and an SD of 8.2 about the baseline mean. 
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to reliably detect up to a 40% change in RAIU 
at the lowest dose tested. Second, in the lowest 
dose group, several subjects exhibited reduced 
RAIU (Greer et al. 2002). Third, perchlorate 
exposures with predicted IUI of < 5% based on 
PBPK modeling were associated with thyroid 
hormone alterations in animal bioassays (U.S. 
EPA 2002c). More recent human data are also 
consistent with perchlorate effects on the thy­
roid in sensitive subgroups at doses predicted 
to cause low levels of IUI. At the median U.S. 
perchlorate dose of 0.066 µg/kg/day, estimated 
from the 2001–2002 NHANES data (Blount 
et al. 2007), IUI of < 1% would be predicted 
based on recent U.S. EPA modeling (U.S. EPA 
2008a, Table 5­4).
Accounting for uncertainties. Consistent 
with U.S. EPA and MA DEP protocols, uncer­
tainty factors (UFs) are used to adjust the 
POD to account for gaps in scientific data and 
knowledge. MA DEP concluded that a total 
UF of 100 was appropriate for deriving an RfD 
for perchlorate. This UF accounts for database 
insufficiencies as well as extrapolation from 
results in a small group of healthy adults to sen­
sitive subgroups and from a minimal LOAEL 
to a no observed adverse effect level (NOAEL). 
An adjustment for database deficiencies was 
included due to a lack of data from chronic 
exposure studies; uncertainty regarding per­
chlorate interference with iodide transport into 
breast milk, which could increase the sensitiv­
ity of the neonate; and uncertainties relating to 
perchlorate’s mode of action, immunotoxicity, 
and possible carcinogenicity.
RfD calculation. Using the minimum 
LOAEL of 7 µg/kg/day and a UF of 100 the 
final MA RfD was calculated as follows:
 
µ
µ
µ.
RfD UF
minimumL OAEL g/kg/day
100
7g /kg/day
0.07 g/kg/day
=
=
=   [1]
Results from animal studies support this, 
or an even lower, RfD (U.S. EPA 2002c) 
[see Supplemental Material, Section C 
(doi:10.1289/ehp.0900635.S1)]. Most SAC 
members supported this RfD. One member 
supported a higher UF of 300, which would 
result in an RfD of 0.02 µg/kg/day. A second 
member supported a UF of 30, which would 
result in an RfD of 0.23 µg/kg/day.
Health-Based Drinking Water 
Guidelines
Approach. The general equation used to convert 
RfDs to a drinking water guideline (DWG) is
  DWG = RSC × RfD × BW ÷ IR,  [2]
where RfD is the reference dose (micrograms 
per kilogram per day), RSC is the relative 
source contribution factor or the fraction of 
the RfD allocated to drinking water (unit­
less), BW is body weight (kilograms), and IR 
is water ingestion rate (liters per day).
The RSC is applied to account for non­
drinking water exposures that contribute to 
overall exposure. When non­drinking water 
exposures are likely but the data are insuffi­
cient to quantify their relative contributions, 
U.S. EPA recommends a default RSC of 20% 
(U.S. EPA 1998). When MA DEP derived its 
DWG for perchlorate in 2005, the available 
data were insufficient to calculate an RSC, and 
we opted to use the 20% default. The cur­
rent database on U.S. perchlorate exposures is 
more robust. Perchlorate was detected in all 
2001–2002 NHANES urine samples, with 
estimated median and 95th percentile intakes 
of 0.066 µg/kg/day and 0.234 µg/kg/day,   
respectively, for adults > 20 years of age 
(Blount et al. 2007). The 2005–2006 FDA 
Total Diet Study (TDS) estimated lower 
bound (average values with nondetects treated 
as zero) perchlorate exposures attributable to 
food ranging from 0.08 µg/kg/day for 25­ to 
30­year­old men to 0.35 µg/kg/day for 2­year­
olds (Murray et al. 2008; U.S. EPA 2008a). 
Using the 2001–2002 NHANES data and 
restricting the analysis to individuals unlikely 
to have drinking water exposure, the U.S. EPA 
estimated mean perchlorate food exposures for 
pregnant women and the total population to 
be 0.123 and 0.090 µg/kg/day, and 90th per­
centile values to be 0.263 and 0.167 µg/kg/day, 
respectively (U.S. EPA 2008a). Thus, most cur­
rent estimates of mean and median perchlorate 
exposures attributable to food exceed the MA 
RfD of 0.07 µg/kg/day and would support an 
RSC of < 20%.
Adult DWG value. Using Equation 2 and a 
20% RSC, the health­based DWG for perchlo­
rate equals 0.49 µg/L for a 70­kg adult consum­
ing 2 L water/day. Use of the alternative RfDs 
supported by some members of the SAC yield 
DWG values of 0.16 and 1.6 µg/L. Because 
many of the recent estimates of perchlorate 
exposures attributable to food exceed the MA 
RfD, a lower DWG could be supported.
Neonatal exposure adjustments. Perchlorate 
risks to neonates are of particular concern 
because of their limited reserve capacity of 
thyroid hormones and incompletely devel­
oped thyroid functions (Pedraza et al. 2006; 
Savin et al. 2003; van den Hove et al. 1999). 
Neonatal exposures also differ from those of 
adults because of higher liquid intakes per unit 
of BW and the consumption of breast milk. 
To address neonatal water ingestion, MA DEP 
derived a DWG using an infant fluid con­
sumption rate of 0.64 L/day and BW of 4 kg 
(U.S. EPA 2002b), which results in a higher 
exposure rate per unit of BW compared with 
adults. For formula­fed infants, whose expo­
sures attributable to other foods are limited, the 
perchlorate DWG calculated using these infant 
parameters, without an RSC, equals 0.44 µg/L.
The situation for the breast­fed infant is 
more complex, because it requires a DWG 
for the lactating mother that appropriately 
accounts for perchlorate entry into breast milk. 
At the time that MA DEP derived its DWG 
for perchlorate, we concluded that it was not 
possible to derive meaningful quantitative 
estimates of infant perchlorate exposures from 
breast milk directly attributable to maternal 
drinking water exposures because of limited 
data and uncertainties in the PBPK models for 
fetal and neonatal life stages. More recent data 
indicate that neonatal exposures to perchlo­
rate in breast milk are significant. The median 
perchlorate exposure to 2­week­old nursing 
infants in the United States was predicted to 
be 0.206 µg/kg/day (95th percentile = 0.744 
µg/kg/day) (Ginsberg et al. 2007). Other data 
indicate that nursing infant perchlorate expo­
sures in the United States can be even higher. 
Based on a breast milk intake rate of 0.172   
L/kg/day and reported median breast milk per­
chlorate concentrations (Kirk et al. 2005, 2007; 
Pearce et al. 2007b), we estimate that nursing 
infant perchlorate intakes in three U.S. cohorts 
ranged from 0.56 to 1.57 µg/kg/day. Dasgupta 
et al. (2008) estimated breast milk perchlorate 
intake rates ranging from 0.3 to 2.1 µg/kg/day, 
with intakes of 9 of 13 infants exceeding the 
NRC RfD (NRC 2005). These data support 
precautionary maternal exposure limits.
MA Drinking Water Standard
The final MA DWS for perchlorate was estab­
lished at 2.0 µg/L. This value was the result 
of a risk management decision that took into 
account the health­based guidelines derived 
above and concerns relating to the pres­
ence of perchlorate in hypochlorite drinking 
water disinfection solutions. Although other 
drinking water treatments exist (e.g., ultra­
violet light) where perchlorate would not be 
a concern, hypochlorite solutions are used at 
many public drinking water supplies (PDWS). 
Depending on a number of factors, hypochlo­
rite solutions can undergo oxidative decom­
position generating chlorate, ClO3
– (Gordon 
and Bubnis 1996). Chlorate can be further 
oxidized, perhaps catalyzed by trace transi­
tion metal contaminants, to generate perchlo­
rate, ClO4
– (Schumacher 1960). Commercial 
sodium hypochlorite solutions from MA 
drinking water and wastewater treatment 
facilities were found to have perchlorate at lev­
els ranging from < 1 µg/L in newly delivered 
solutions to 6,750 µg/L in solutions stored for 
26 days postdelivery (mean = 2,461 µg/L in 
the 26­day­old solutions) (Table 1). Similar 
levels were also detected in household bleach, 
with higher levels also found in older solu­
tions. Ninety­one percent of 82 commercial 
sodium hypochlorite drinking water treatment Zewdie et al.
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solutions were found to contain perchlorate 
at concentrations that would result in, at 
the certified maximum use level of 10 mg/L 
chlorine, treated drinking water perchlorate 
concentrations ranging from 0.03 to 29 µg/L 
(Greiner et al. 2008). At the certified maxi­
mum use level, 40% of the hypochlorite solu­
tions tested would lead to finished drinking 
water perchlorate concentrations in excess of 
1 µg/L, and 29% in excess of 2 µg/L (Greiner 
et al. 2008). Perchlorate from the use of hypo­
chlorite disinfection solutions would add to 
any existing level of this agent in the source 
water and could create compliance issues at 
PDWS attributable to prechlorination, chlo­
rination, and shock chlorination treatments of 
water supplies to address pathogens.
In light of these findings and to avoid the 
creation of potential compliance issues that 
could create disincentives for necessary water 
supply disinfection, MA DEP established the 
DWS at 2 µg/L following extensive public 
hearings. MA DEP concluded that this value 
would reasonably minimize potential perchlo­
rate exceedences attributable to chlorination, 
balancing perchlorate exposure and infectious 
disease control concerns. This value was also 
determined to be within the range of scientific 
uncertainty regarding perchlorate toxicity.
Discussion
The MA RfD and DWS are lower than related 
values derived by U.S. EPA, NRC, and CalEPA 
(Table 2). Although all three groups relied on 
the IUI results of Greer et al. (2002), they dif­
fered in their treatment of this end point and 
in the selection of UFs. Views on the signifi­
cance of IUI vary. The NRC considered IUI 
to be a nonadverse precursor effect but relied 
on this end point as the key effect in their RfD 
derivation, treating the lowest dose from Greer 
et al. (2002) as a no­effect level. They further 
suggested that IUI would be unlikely to lead to 
adverse effects unless the degree of inhibition 
was very large (75%) (NRC 2005). CalEPA 
used a 5% IUI response rate in their BMD 
modeling (Ting et al. 2006). The U.S. EPA 
recently concluded that PBPK model­predicted 
IUI of up to 2.2% in bottle­fed infants would 
not be significant (U.S. EPA 2008a). However, 
the level of IUI necessary to cause deleteri­
ous downstream effects is unknown, and the 
available data suggest that small increments in 
IUI may be significant. In rodents, perchlorate 
doses estimated to cause PBPK modeled IUI 
of < 5% were associated with altered thyroid 
hormone status and possible developmental 
effects (U.S. EPA 2002c). Additionally, per­
chlorate intakes estimated from the 2001–2002 
NHANES data (Blount et al. 2007) would be 
predicted to cause IUI of < 1% on the basis 
of the U.S. EPA modeling (U.S. EPA 2008a). 
Thyroid hormone alterations in women with 
urinary iodine < 100 µg/L were associated with 
perchlorate exposures in this study population 
(Blount et al. 2006a; Steinmaus et al. 2007). 
These observations suggest one of the follow­
ing: unexpectedly small increments in IUI 
may cause thyroid effects, perchlorate may act 
through additional mechanisms, or the model 
estimates of IUI are inaccurate.
Although other epidemiological stud­
ies with direct measures of exposure have not 
demonstrated perchlorate­associated thyroid 
effects, they suffer from a number of limitations 
compared with the 2001–2002 NHANES 
analyses. In one case, the cohort included only 
16 individuals (Gibbs and van Landingham 
2008); two involved cohorts with higher iodine 
intakes (Amitai et al. 2007; Tellez et al. 2005); 
and one report lacked sufficient detail to eval­
uate the analysis (Pearce et al. 2007a). Thus, 
although the epidemiology is not consistent, 
studies on the largest cohort did find an associa­
tion between perchlorate and thyroid effects in 
women with urinary iodide levels < 100 µg/L 
at exposures commonly encountered in the 
U.S. population and well below the NRC RfD. 
Thus, based on the available data, MA DEP 
believes that its decision to treat the lowest dose 
of the Greer et al. (2002) study as a minimal 
adverse effect is appropriate.
The selection of UFs is open to differing 
interpretations of the science. The NRC used 
a UF of 10 to account for human variability 
and included no other UFs, resulting in an 
RfD of 0.7 µg/kg/day. The NRC committee 
itself was not unanimous on this issue, with 
one member stating that a higher UF (30) was 
warranted to account for database uncertainties 
(NRC 2005). This would lead to an RfD of   
0.23 µg/kg/day. CalEPA used a UF of 10 for 
human variability, which yields an RfD of 0.37   
µg/kg/day based on their BMDL­derived POD 
(Ting et al. 2006). The U.S. EPA adopted the 
NRC RfD. Had the U.S. EPA BMDL esti­
mate been used as the POD, with applica­
tion of a UF of 10, the RfD would have been 
0.20 µg/kg/day. In the derivation of the MA 
RfD of 0.07 µg/kg/day, a UF of 100 was used 
to account for uncertainties relating to human 
variability, minimal LOAEL to NOAEL 
extrapolation, and database deficiencies.
The differences in the health­based drinking 
water values between these groups are largely 
attributable to the use of different RfD and 
RSC values. Compared with MA DEP, the use 
of higher RfD values by U.S. EPA and CalEPA 
allow for greater total exposures and thus higher 
RSC values. The California drinking water 
value of 6 µg/L was derived using an RfD of 
0.37 µg/kg/day; an RSC of 60%, supported by 
data from Valentin­Blasini et al. (2005); and 
the BW and water intake rate of the pregnant 
woman (Ting et al. 2006). The recent U.S. 
EPA IDWHA of 15 µg/L for perchlorate was 
Table 1. Perchlorate concentrations in sodium hypochlorite (NaOCl) solutions.
No. of 
samples
Perchlorate (µg/L)
Source Mean Range Comments
Drinking water treatment plant newly 
delivered 15% NaOCl solution
1 < 0.2 Not applicable
Drinking water treatment plant 26-day 
postdelivery 15% NaOCl
5 2,461 490–6,750a
Household bleach 5 1,834 89–8,000a Highest values from oldest bottle
Wastewater treatment plant 
15% NaOCl
3 2,753 260–4,600a
3 2,163 900–4,100b
aAnalyzed using U.S. EPA method 331.0 (U.S. EPA 2005b). bAnalyzed using U.S. EPA method 314.0 (U.S. EPA 1999).
Table 2. Perchlorate RfDs and drinking water values by various agencies.
Parameter MA DEP NRC majority U.S. EPA CalEPA
POD Greer et al. (2002) low-dose group as 
minimum LOAEL
Greer et al. (2002) low-dose 
group as no effect level
Adopted NRC value Greer et al. (2002) 
BMDL at 5% IUI
UF  100 10 (30a) Adopted NRC value 10
Basis of UF Minimum LOAEL to NOAEL; sensitive 
subgroups; data gaps
Sensitive subgroups Adopted NRC value Sensitive subgroups
RfD (µg/kg/day) 0.07 0.7 (0.23b) Adopted NRC value 0.37
Relative source contribution factor 20% Not calculated 60% 60%
Adult drinking water value (µg/L) 0.49 (2c) Not calculated 15 6d
Infant drinking water value (µg/L) 0.43e Not calculated (4.3e) Not calculated (3f) Not calculated
aOne member of the NRC and SAC supported a UF of 30 (MA DEP 2006; NRC 2005). bRfD using UF = 30. cMA DWS was based on risk management considerations. dThe California Public 
Health Goal was based on an RSC of 60% and BW and water consumption rate of the pregnant woman (Ting et al. 2006). eDrinking water value calculated by MA DEP using infant BW 
of 4 kg, water consumption of 0.64 L/day, and RSC = 100%. fDrinking water value necessary for bottle-fed infants to meet NRC RfD based on exposure estimate in U.S. EPA (2008a).Massachusetts perchlorate drinking water standard
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based on the NRC RfD of 0.7 µg/kg/day and 
an RSC estimate of 60% derived from dietary 
exposure estimates from the FDA­TDS and 
NHANES data (U.S. EPA 2008a).
Notably, the document supporting the 
U.S. EPA IDWHA estimated that perchlorate 
intake by nursing infants, bottle­fed infants, 
and children to 2 years of age, attributable to 
either maternal perchlorate intake and sub­
sequent expression into breast milk, or direct 
infant consumption of water with perchlorate 
at 15 µg/L, would substantially exceed the 
NRC RfD (U.S. EPA 2008a). At the health 
advisory level of 15 µg/L, a bottle­fed infant 
would receive a dose of perchlorate five times 
higher than the NRC RfD, suggesting that a 
perchlorate advisory level of 3 µg/L would be 
needed to protect children’s health. However, 
the U.S. EPA discounted this information, 
basing their conclusion on the results of PBPK 
modeling, which was used to predict perchlo­
rate IUI across various life stages (U.S. EPA 
2008a). The U.S. EPA noted that the model 
did not take into account within­group vari­
ability in pharmacokinetics, uncertainty in 
model parameters and predictions, differences 
in adaptive responses, or responses in those 
with insufficient iodine intakes. Despite these 
limitations, the U.S. EPA used the model to 
predict IUI of 1.1% in the fetus, 1.3% in the 
7­day­old nursing infant, and 2.2% in the 
7­day­old bottle­fed infant for combined per­
chlorate intakes from food and drinking water 
at 15 µg/L (U.S. EPA 2008a). Premature 
infants, identified as a particularly vulnerable 
group (NRC 2005), were not addressed. The 
U.S. EPA concluded that these IUI levels were 
not significant. However, these predictions 
provide little assurance that the IDWHA is 
health protective for the iodide­deficient fetus 
and neonate because the model uncertainties 
are substantial and because animal data (U.S. 
EPA 2002c) and human data (Blount et al. 
2006a, 2007) suggest that perchlorate may 
affect thyroid function at doses predicted to 
cause little IUI (U.S. EPA 2008a). Thus, based 
on current information, the IDWHA may not 
sufficiently protect sensitive life stages.
More recently, the U.S. EPA Office of 
the Inspector General (OIG) completed a 
draft assessment that used a cumulative risk 
approach to derive estimated NIS inhibitor 
loads attributable to exposures to perchlorate, 
nitrate, and thiocyanate (U.S. EPA 2008b). 
Although aspects of the OIG’s assessment 
have merit, external scientific review has not 
yet been completed. Briefly, the OIG esti­
mated that perchlorate exposure at the NRC 
RfD would contribute < 1% of an adult’s typi­
cal total NIS inhibitor load. The OIG draft 
report also evaluated studies on nitrate­ and 
thiocyanate­exposed populations and con­
cluded that they, on a perchlorate­equivalent 
exposure basis, support the NRC perchlorate 
RfD. However, the limitations of the epidemio­
logical studies included were not fully consid­
ered, and the results of the Blount et al. (2006a) 
and Steinmaus et al. (2007) analyses were not 
addressed.
If the OIG report’s analysis of NIS inhibitor 
intake is correct, exposures to thyroid toxicants 
may, based on NIS inhibition, be too high for a 
significant number of people. As a public health 
response, the OIG concluded that 
the most effective and efficient approach for 
reducing health risks of permanent mental defi­
cits in children from low maternal thyroid iodide 
uptake during pregnancy and nursing (for exam­
ple, attributable to exposures to perchlorate, other 
NIS inhibitors, and iodide insufficiency) is to add 
iodide to all prenatal vitamins. 
We believe that this is an insufficient response 
because, in the case of contaminated water sup­
plies, it shifts the responsibility for protect­
ing public health away from those responsible 
for environmental pollutants to the individu­
als who bear the risk. Additionally, under this 
intervention approach, protection of infants 
from adverse health effects attributable to   
perchlorate­contaminated water supplies would 
be completely dependent on the mother’s 
ability to achieve the necessary iodide supple­
mentation. We believe that more comprehen­
sive policies to reduce exposures to thyroid 
toxicants are also needed.
Conclusions
MA DEP used a weight­of­the­evidence 
approach using mode­of­action, human, and 
animal data to assess perchlorate risk and 
selected data from the Greer at al. (2002) study 
to derive an RfD. Because of potential neuro­
development risks to children, scientific uncer­
tainties were addressed in a health­protective 
manner. MA DEP identified the lowest dose 
level in the Greer et al. (2002) study as a mini­
mum LOAEL, which was used as the POD 
to derive an RfD. A number of limitations 
and uncertainties in the perchlorate database 
were identified and a range of UFs were con­
sidered to address these. The MA DEP SAC 
supported UF values ranging from 30 to 300, 
with associated RfDs of 0.23 µg/kg/day and 
0.02 µg/kg/day. MA DEP scientists and most 
SAC members concluded that a composite UF 
of 100 was most appropriate, resulting in a 
final RfD value of 0.07 µg/kg/day. Data from 
animal studies support a similar or perhaps 
even lower value [see Supplemental Materials, 
Section C (doi:10.1289/ehp.0900635.S1)].
To account for other sources of exposure, 
MA DEP applied a default RSC of 20% to 
derive a health­based drinking water value of 
0.49 µg/L for adults. More recent data indicate 
that food exposures to perchlorate are close 
to, or even exceed, the MA RfD (U.S. EPA 
2008a), which would support a lower RSC. 
The final MA DWS for perchlorate was set 
at 2 µg/L based on a risk management deci­
sion to minimize potential compliance issues 
at PDWS attributable to perchlorate in chlo­
rination disinfection treatments. A standard 
of 2 µg/L minimizes possible disincentives to 
adequate chlorination, which could raise drink­
ing water risks from pathogens. MA DEP con­
cluded that this standard reasonably balanced 
potential perchlorate exposure and infectious 
disease concerns and was also within the range 
of scientific uncertainty regarding perchlorate 
toxicity.
Estimates of exposures to perchlorate and 
other thyroid toxicants, combined with data 
indicating that significant numbers of U.S. 
women are iodide insufficient, point to the 
need for more comprehensive approaches and 
policies to address and reduce exposures to 
thyroid toxicants in drinking water, breast 
milk, and food and to improve iodide intake. 
Pending further scientific developments, 
including explanation or confirmation of 
the observations of Blount et al. (2006a) and 
Steinmaus et al. (2007), we believe that the 
MA RfD and DWS are supported by the avail­
able data and, compared with current U.S. 
EPA values, better protect children’s health.
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